BLCM logo

Bellicum Pharmaceuticals (BLCM) Shareholders Equity

BLCM Annual Shareholders Equity

$2.02 M
-$22.38 M-91.74%

31 December 2022

BLCM Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BLCM Quarterly Shareholders Equity

-$27.01 M
-$5.17 M-23.69%

01 September 2023

BLCM Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BLCM Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-91.7%-460.2%
3 y3 years+107.7%+43.8%
5 y5 years-97.6%-129.2%

BLCM Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time-98.9%-114.1%

Bellicum Pharmaceuticals Shareholders Equity History

DateAnnualQuarterly
Sept 2023
-
-$27.01 M(+23.7%)
June 2023
-
-$21.84 M(+118.0%)
Mar 2023
-
-$10.02 M(-597.3%)
Dec 2022
$2.02 M(-91.7%)
$2.02 M(-73.1%)
Sept 2022
-
$7.50 M(-46.6%)
June 2022
-
$14.04 M(-19.5%)
Mar 2022
-
$17.43 M(-28.6%)
Dec 2021
$24.39 M(-1077.0%)
$24.39 M(-300.5%)
Sept 2021
-
-$12.16 M(-14.6%)
June 2021
-
-$14.24 M(+10.7%)
Mar 2021
-
-$12.86 M(+415.1%)
Dec 2020
-$2.50 M(-90.5%)
-$2.50 M(-94.8%)
Sept 2020
-
-$48.03 M(-1.5%)
June 2020
-
-$48.78 M(+580.3%)
Mar 2020
-
-$7.17 M(-72.6%)
Dec 2019
-$26.22 M(-138.3%)
-$26.22 M(-2233.2%)
Sept 2019
-
$1.23 M(-95.9%)
June 2019
-
$30.31 M(-40.4%)
Mar 2019
-
$50.86 M(-25.7%)
DateAnnualQuarterly
Dec 2018
$68.48 M(-19.1%)
$68.48 M(-25.9%)
Sept 2018
-
$92.46 M(-17.8%)
June 2018
-
$112.54 M(+70.0%)
Mar 2018
-
$66.18 M(-21.8%)
Dec 2017
$84.65 M(-12.3%)
$84.65 M(-17.9%)
Sept 2017
-
$103.12 M(-16.0%)
June 2017
-
$122.71 M(-14.3%)
Mar 2017
-
$143.12 M(+48.2%)
Dec 2016
$96.57 M(-36.5%)
$96.57 M(-14.6%)
Sept 2016
-
$113.09 M(-11.3%)
June 2016
-
$127.49 M(-9.2%)
Mar 2016
-
$140.37 M(-7.7%)
Dec 2015
$152.02 M(-20.7%)
$152.02 M(-8.5%)
Sept 2015
-
$166.10 M(-6.2%)
June 2015
-
$177.01 M(-4.5%)
Mar 2015
-
$185.36 M(-3.3%)
Dec 2014
$191.64 M(-780.7%)
$191.64 M(-594.0%)
Sept 2014
-
-$38.79 M(+37.8%)
Dec 2013
-$28.15 M(+44.6%)
-$28.15 M
Dec 2012
-$19.47 M
-

FAQ

  • What is Bellicum Pharmaceuticals annual stockholders equity?
  • What is the all time high annual shareholders equity for Bellicum Pharmaceuticals?
  • What is Bellicum Pharmaceuticals annual shareholders equity year-on-year change?
  • What is Bellicum Pharmaceuticals quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Bellicum Pharmaceuticals?
  • What is Bellicum Pharmaceuticals quarterly shareholders equity year-on-year change?

What is Bellicum Pharmaceuticals annual stockholders equity?

The current annual shareholders equity of BLCM is $2.02 M

What is the all time high annual shareholders equity for Bellicum Pharmaceuticals?

Bellicum Pharmaceuticals all-time high annual stockholders equity is $191.64 M

What is Bellicum Pharmaceuticals annual shareholders equity year-on-year change?

Over the past year, BLCM annual stockholders equity has changed by -$22.38 M (-91.74%)

What is Bellicum Pharmaceuticals quarterly stockholders equity?

The current quarterly shareholders equity of BLCM is -$27.01 M

What is the all time high quarterly shareholders equity for Bellicum Pharmaceuticals?

Bellicum Pharmaceuticals all-time high quarterly stockholders equity is $191.64 M

What is Bellicum Pharmaceuticals quarterly shareholders equity year-on-year change?

Over the past year, BLCM quarterly stockholders equity has changed by -$34.51 M (-460.23%)